Serum markers for prognostic value of EGFR-TKI in lung adenocarcinoma with bone metastases: a retrospective study

Background Lung adenocarcinoma is a prevalent malignancy. Mutations in the epidermal growth factor receptor (EGFR) have introduced novel prospects for targeted therapies. However, the status of EGFR mutations alone may be insufficient to fully predict treatment outcomes. To this end, the present res...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Jiali Li, Shuting Wang, Zhiyong Deng, Lu Zhang, Min Liu, Yunlei Luo, Yunqiu Guo, Pengjie Liu, Chao Liu
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	PeerJ Inc. 2026-01-01
Ráidu:	PeerJ
Fáttát:	Lung adenocarcinom Serum markers EGFR-TKI Bone metastases Prognostic prediction
Liŋkkat:	https://peerj.com/articles/20537.pdf
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!